ARCHIVES

In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 01 | January 7, 1977

Download PDF Visit The Full Archive

Related Articles

Urologists support Approval Of Il-2 for Kidney Cancer

February 1, 1991

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Chabner On Taxol, NSABP: “Makes You Lose Confidence In The Political Process”

May 12, 1995